Litcius/Paper detail

Efficacy and safety of ZX-7101A, an inhibitor of influenza cap-dependent endonuclease, in adults with uncomplicated influenza: a randomized, double-blind, placebo-controlled phase 2/3 trial

Hongyu Wang, Gang Wang, Yan Gao, Lihong Qu, Hong Wang, Min Deng, Hainv Gao, Yilin Li, Nan Yang, Baogui Wang, Rongge Liu, Xuzhu Ma, Zhen Tao, Guoqiang Zhang, Qian Wang, Weifeng Zhao, Yunsong Yu, Lin Chen, Lianchun Liang, Shengyu Wang, Lei Shao, Tao Yang, Jinglei Cao, Yuan Cao, Xiaoli Qin, Jingwen Ai, Huadong Zhu, Wenhong Zhang

2024Clinical Microbiology and Infection13 citationsDOIOpen Access PDF

Topics & Concepts

PlaceboMedicineDouble blindInternal medicineEndonucleasePhase (matter)VirologyBiologyPathologyChemistryEnzymeAlternative medicineBiochemistryOrganic chemistryInfluenza Virus Research StudiesCRISPR and Genetic EngineeringRespiratory viral infections research
Efficacy and safety of ZX-7101A, an inhibitor of influenza cap-dependent endonuclease, in adults with uncomplicated influenza: a randomized, double-blind, placebo-controlled phase 2/3 trial | Litcius